CAJ | 학술논문

孤立性纤维性肿瘤（SFT）是一种来源于间叶组织的梭形细胞性肿瘤。该病早期临床症状隐匿，常因肿瘤增大压迫周围组织而被发现，CT和（或） MRI是诊断SFT的常用手段，确诊需行病理活组织检查及免疫组织化学检查。该文报告1例巨大SFT患者，其以大量胸腔积液为首发表现且伴胸闷、呼吸困难等症状。行胸腔引流术后完善胸部CT检查，结果提示为左侧胸腔顶部肿物，由左锁骨下动脉供血，血供较丰富，考虑为壁层胸膜恶性肿瘤。其后行肿瘤血管栓塞术，待肿瘤缩小后行手术将其完全切除，术后病理活组织检查结果为SFT，患者术后恢复良好。由此可见，手术是治疗SFT的首选治疗方法，由于SFT血供常较丰富，故肿瘤较大时可于术前行肿瘤血管栓塞术，待肿瘤缩小后再行手术切除，以降低手术难度及风险，提高手术成功率。
고립성섬유성종류（SFT）시일충래원우간협조직적사형세포성종류。해병조기림상증상은닉，상인종류증대압박주위조직이피발현，CT화（혹） MRI시진단SFT적상용수단，학진수행병리활조직검사급면역조직화학검사。해문보고1례거대SFT환자，기이대량흉강적액위수발표현차반흉민、호흡곤난등증상。행흉강인류술후완선흉부CT검사，결과제시위좌측흉강정부종물，유좌쇄골하동맥공혈，혈공교봉부，고필위벽층흉막악성종류。기후행종류혈관전새술，대종류축소후행수술장기완전절제，술후병리활조직검사결과위SFT，환자술후회복량호。유차가견，수술시치료SFT적수선치료방법，유우SFT혈공상교봉부，고종류교대시가우술전행종류혈관전새술，대종류축소후재행수술절제，이강저수술난도급풍험，제고수술성공솔。
Solitary fibrous tumor (SFT)of the pleura is a type of spindle cell tumor originating from the mesenchymal tissue. The symptoms of SFT are elusive during the early stage and are constantly identified due to tissue compression by enlarged tumors. CT and (or)MRI are the most commonly used diagnostic tools for SFT,whereas the final diagnosis should be confirmed by histopathological and immunohistochemical exami-nations. In this paper,we reported one case of giant SFT presenting with a large amount of pleural effusion as the primary manifestation,and accompanied with chest tightness,dyspnea and other symptoms. CT examina-tion after chest drainage revealed a mass in the left thoracic cavity,the blood of the tumor was supplied by the left subclavian artery and the blood supply was relatively sufficient,which was considered as a malignant tumor of the parietal pleura. Interventional embolization was performed to block the tumor's blood supply and the shrinking tumor was completely resected and diagnosed as SFT by histopathological examination. Therefore, surgery remains the primary treatment of SFT. Due to the sufficient blood supply of the tumor,preoperative in-terventional embolization should be conducted to minimize the tumor size. Then,surgical resection could be performed,which reduces the difficulty and risk of the surgery and enhances surgical success rate.